| __timestamp | Amgen Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 68205000 |
| Thursday, January 1, 2015 | 4070000000 | 54218000 |
| Friday, January 1, 2016 | 3840000000 | 15934000 |
| Sunday, January 1, 2017 | 3562000000 | 24390000 |
| Monday, January 1, 2018 | 3737000000 | 25389000 |
| Tuesday, January 1, 2019 | 4116000000 | 72324000 |
| Wednesday, January 1, 2020 | 4207000000 | 184809000 |
| Friday, January 1, 2021 | 4819000000 | 205164000 |
| Saturday, January 1, 2022 | 4434000000 | 245441000 |
| Sunday, January 1, 2023 | 4784000000 | 271823000 |
| Monday, January 1, 2024 | 5964000000 |
Cracking the code
In the ever-evolving landscape of biotechnology, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Amgen Inc. and Madrigal Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
Amgen, a giant in the biotech industry, consistently allocated substantial resources to R&D, with expenses peaking at nearly 4.8 billion in 2021. This represents a steady increase of approximately 35% from 2014. In contrast, Madrigal Pharmaceuticals, a smaller player, showed a remarkable growth trajectory, with R&D expenses surging by over 3000% from 2014 to 2023, reaching around 272 million.
This data highlights the diverse strategies employed by established and emerging biotech firms, reflecting their unique roles in driving medical advancements and shaping the future of healthcare.
Analyzing R&D Budgets: Amgen Inc. vs Zoetis Inc.
Research and Development: Comparing Key Metrics for Amgen Inc. and Alnylam Pharmaceuticals, Inc.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Amgen Inc. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc.
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and HUTCHMED (China) Limited